Yuki Noguchi

speaker
586 appearances 109 recordings 1 series first heard Feb 2025 last heard 6 Sep

Yuki Noguchi’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
19 · Jul OctJan 26AprJulnow

Recordings per month over the last 12 months — 83 in all, peaking in Jul 2026 with 19.

Appearances

newest first · ▶ plays the moment
Other studies, also published by the American Society of Clinical Oncology, looked at breast cancer incidence.
One found GLP-1 use correlated with a 30 percent lower incidence of disease.
Obesity increases risk of at least a dozen cancers by increasing hormones and inflammation that foster tumors.
But researchers say there may be some additional metabolic benefit from GLP-1s that prime the body against cancer, other than just weight loss.
The data is from a Phase III clinical study on a drug called Daraxanracib.
It's a breakthrough in that it locks into pancreatic cancer cells in a clever way when certain genetic mutations are present.
Julie Graylow is chief medical officer at the American Society of Clinical Oncology, which publishes the most promising research during its annual meeting.
Though it is not yet Food and Drug Administration approved, the agency has already expanded early patient access to it.
Yuki Noguchi, NPR News.
The data is from a phase three clinical study on a drug called Deraxanracib.
It's a breakthrough in that it locks into pancreatic cancer cells in a clever way when certain genetic mutations are present.
Julie Graylow is chief medical officer at the American Society of Clinical Oncology, which publishes the most promising research during its annual meeting.
Though it is not yet Food and Drug Administration approved, the agency has already expanded early patient access to it.
Yuki Noguchi, NPR News.
The Cancer Society, along with the influential U.S.
Preventative Services Task Force, already recommends adults with no family history of colon cancer to begin getting colonoscopy screenings at age 45.
But people are getting diagnosed with the disease at earlier ages, often at advanced stages.
It's now the top cancer killer among those under age 50.
Yet colorectal cancers are slow growing and highly treatable if caught early.
So the American Cancer Society is changing its guideline to add a blood test screening.
Showing 201–220 of 586 · page 11 of 30 ← Previous Next →